# Marc‐Oliver Grimm

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marc-oliver-grimm/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,543 |
| Field | Bladder and Urothelial Cancer Treatments |
| h-index | 54 |
| i10-index | 158 |
| Last Known Institution | Schiller International University |
| OpenAlex ID | https://openalex.org/A5006337629 |
| ORCID iD | https://orcid.org/0000-0003-3084-8654 |
| Works | 527 |

## Researcher papers

- [Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-plus-ipilimumab-versus-sunitinib-in-advanced-renal-cell-carcinoma/)
- [Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial](https://scholariq.org/papers/ramucirumab-plus-docetaxel-versus-placebo-plus-docetaxel-in-patients-with/)
- [Assessment of PI-RADS v2 for the Detection of Prostate Cancer](https://scholariq.org/papers/assessment-of-pi-rads-v2-for-the-detection-of-prostate-cancer/)

## Researcher topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Urinary and Genital Oncology Studies](https://scholariq.org/topics/urinary-and-genital-oncology-studies-2/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Researcher university

- [Schiller International University](https://scholariq.org/institutions/schiller-international-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.